Dr. Naresh Bumma, MD

Dr. Bumma practices at Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center.

Dr. Bumma's NPI, 1346504412, was assigned on July 3, 2012. Dr. Bumma graduated from All India Institute of Medical Sciences in 2011. Dr. Bumma holds Ohio license 35.125200.

Dr. Bumma's primary practice is Ohio State University Hospital, at 410 West 10th Avenue, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-9700.

Dr. Bumma's primary practice is Ohio State University Hospital in Columbus, Ohio, part of The Ohio State University Wexner Medical Center. Dr. Bumma is also affiliated with The James Cancer Hospital and Solove Research Institute. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Bumma to 2 more hospital outpatient departments and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bumma practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bumma's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Bumma is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bumma's licenses on file in 2 states: Ohio and Michigan.

Dmand AI lists anemia, chronic leukemia and multiple myeloma among the conditions Dr. Bumma treats.

CMS data shows 720 Medicare services from Dr. Bumma across 7 procedure codes in 2024, for 257 Medicare patients. Medicare paid $61,602 for them.

CMS counts 257 Medicare patients who saw Dr. Bumma in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bumma's median patient age at 68, with 44% women.

In 2024, Dr. Bumma wrote 339 Medicare Part D claims for 82 patients. 69% of them were for generic drugs. CMS names the drug for 207 of them, across 7 drugs with 11 or more claims each, at $1,100,967 in total drug cost. In 2023, CMS named 134 claims across 6 drugs.

Dr. Bumma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bumma as offering telehealth.

Dmand AI links 52 papers to Dr. Bumma, published from 2015 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Lenalidomide. Dr. Bumma has published most often in Front Oncol. Dr. Bumma's most frequent co-authors are Srinivas Sankarnaga Devarakonda, MD, Don Michael Benson, MD and Yvonne A. Efebera, MD.

Dmand AI links Dr. Bumma to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Bumma that name 2 trials.

CMS Open Payments shows 149 general payments to Dr. Bumma from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Amgen Inc. paid the most, $55,254. It also lists 83 research payments totaling $31,331 from 2021 to 2025, naming 2 clinical trials.

Dmand AI lists 4 awards for Dr. Bumma, most recently Abstract Achievement Award in 2017.

Dr. Bumma graduated from All India Institute of Medical Sciences in 2011.

Dr. Bumma is in network with 8 carriers, including Aetna, Molina and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.